Presentation Information
[PE-129]Beyond Convential therapy targeting multiple pathways: Combination Tofacitinib-Ustekinumab in Refractory Crohn's disease
*Bhaskar Kante1, Sreekanth Appasani1, Harshavardhan Reddy1, Venu Gongati1, Spoorthi Kolla1, Vishwanath Kamisetty1, Srinu Deshidi1, Harshavardhan Telaprolu1 (1. Krishna Institue of Medical Sciences , Hyderabad, Telangana, India)
Password required to view
Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.
The password will be emailed to those who have completed the registration.
Comment
To browse or post comments, you must log in.Log in